The FROGG 2022 Workshop Program is subject to change

Click Here to Download
Friday 9 September
Session 1: Precision Medicine/Genomics
Session Chair: Dr David Christie
0820 – 0830 Welcome
0830 – 0900 Precision Medicine and Genomics in Prostate Cancer
Prof Daniel Spratt
0900 – 0930 Patient selection for an Active Surveillance Strategy – A Precision Medicine focus.
A/Prof Niall Corcoran
0930 – 1000 Using PSMA/Imaging as a Prostate Biomarker
Prof Louise Emmett
1000 – 1015 Challenges and limitations in implementation of prostate molecular biomarkers into
Australian clinical practice and trials
Dr Niluja Thiruthaneeswaran
1015 – 1045 Morning Refreshments
Session 2: Definitive Prostate Cancer
Session Chair: Dr Amy Hayden
1045 – 1115 Focal Boost for Prostate Cancer – when and how?
Dr Alison Tree
1115 – 1145 State of Hypofractionation in Australia and PCOR data – when to do it, and when not
A/Prof David Pryor
1145 – 1215 Stereotactic Body Radiotherapy (SBRT) for Localised Prostate Cancer
Dr Alison Tree
1215 – 1245 Optimising Androgen Deprivation Therapy (ADT) for Prostate Cancer Radiotherapy
Prof Daniel Spratt
1245 – 1345 Lunch
Session 3: Panel Discussion, Nodal Radiotherapy and Salvage Brachytherapy
Session Chair: Dr Braden Higgs
1345 – 1430 Case Management Discussion Panel – Localised, Intact Prostate Cancer
Dr Alison Tree, Prof Daniel Spratt, Dr Sarat Chander, A/Prof David Pryor
1430 – 1445 Elective Nodal RT – Implications from the POP-RT Trial
Dr Shreya Armstrong
1445 – 1500 Salvage High Dose Rate Brachytherapy (HDR): Global overview and local experience
Dr Raghu Gowda
1500 – 1530 Optimising Management for Node Positive, M0 Prostate Cancer
Prof Chris Parker
1530 – 1600 Afternoon Refreshments
Session 4 – Planning Workshop
Workshop Coordinator: Dr Mark Sidhom
1600 – 1715 SBRT Prostate, DIL Boost (Dominant Intraprostatic Nodule)
Prof Daniel Spratt, Dr Alison Tree, Dr Tom Eade, Dr Giuseppe Sasso
Saturday 10 September
Session 5: Post-prostatectomy RT/Nodal Therapy
Session Chair: A/Prof Tom Shakespeare
0830 – 0900 Post Prostatectomy Radiotherapy: timing is everything
Prof Chris Parker
0900 – 0930 Optimising Post-prostatectomy Radiotherapy
Prof Daniel Spratt
0930 – 0945 Patterns of Local Failure and Impact on Treatment Volumes: Lessons from the PET
Department
Dr Patrick Horsley
0945 – 1000 Using Image Guidance to determine optimal Post Prostatectomy Radiotherapy Margins
Linda Bell
1000 – 1030 FROGG Patterns of Care Survey Results Presentation and Panel Discussion
Dr Anna Lawless
Panel – A/Prof Niall Corcoran, A/Prof Andrew Kneebone
1030 – 1100 Morning Refreshments
Session 6: FROGG Guidelines Session
1100 – 1245 Revision of FROGG Post Prostatectomy Treatment Guidelines
Advisory Panel
Dr Alison Tree, Prof Daniel Spratt, Dr Tanya Holt, A/Prof Andrew Kneebone
1245 – 1345 Lunch
Session 7: Metastatic Prostate
Session Chair: Dr Renee Finnegan
1345 – 1415 Oligometastatic disease and Oligo Progression: Place of Metastasis Directed Therapy
(MDT)
Dr Alison Tree
1415 – 1445 Systemic Therapy for Small and Large Volume Metastatic Prostate Cancer: When and
What?
Dr Melanie Wuttke
1445 – 1505 The Great Debate
High risk prostate cancer – cut it out / keep it in
Prof Daniel Spratt, A/Prof Niall Corcoran
1505 – 1530 FROGG AGM
FROGG Chairperson – Dr Tanya Holt
1530 – 1545 Afternoon Refreshments
1545 – 1645 FROGG Executive Meeting